Pair Name | Polydatin, Brusatol | ||
Phytochemical Name | Polydatin (PubChem CID: 5281718 ) | ||
Anticancer drug Name | Brusatol (PubChem CID: 73432 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Polydatin, Brusatol | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Gene Regulation | Down-regulation | Expression | HMOX1 | hsa3162 |
Down-regulation | Expression | NFE2L2 | hsa4780 | |
Down-regulation | Expression | NQO1 | hsa1728 | |
In Vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 |
SUM159PT | Breast pleomorphic carcinoma | Homo sapiens (Human) | CVCL_5423 | |
In Vivo Model | MDA-MB-231 (100 μL containing 5×10⁶ cells) were injected subcutaneously into nude mice. Until the tumor volume reached 100–200 mm3, mice in the individual administration groups were injected intraperitoneally with PD 50 mg/kg, the combined administration group was PD 25 mg/kg and BRU 1 mg/kg. | |||
Result | We could significantly reduce tumor cell growth while avoiding toxic side effects, providing a treatment method with greater clinical application value for TNBC treatment. |
No. | Title | Href |
---|---|---|
1 | Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway. Int J Mol Sci. 2023 May 5;24(9):8265. doi: 10.3390/ijms24098265. | Click |